Target intelligence / Profile preview

Beta-lactamase class A and beta-lactamase class C enzyme (Class A β-lactamase, Class C β-lactamase)

Target
Class A β-lactamase, Class C β-lactamase
Molecular classification
Enzyme, Hydrolase, Serine hydrolase
01

Overview

Beta-lactamase class A and beta-lactamase class C enzymes are bacterial serine hydrolases responsible for inactivating β-lactam antibiotics, such as penicillins and cephalosporins, by hydrolyzing their characteristic four-membered β-lactam ring. Class A β-lactamases include penicillinases, some cephalosporinases, and extended-spectrum β-lactamases (ESBLs), which confer resistance to a broad range of β-lactams and are generally inhibited by active-site inhibitors like clavulanic acid. Class C β-lactamases, commonly called AmpC enzymes or cephalosporinases, primarily hydrolyze cephalosporins (including some expanded-spectrum agents) and are not effectively inhibited by traditional β-lactamase inhibitors like clavulanic acid, but can be inhibited by newer agents such as avibactam. These enzymes are major contributors to antibiotic resistance in clinically important Gram-negative bacteria and represent priority therapeutic targets for infection control.

Other names
Class A serine β-lactamaseClass C cephalosporinaseSerine β-lactamase (for A and C)AmpC β-lactamase (for class C)ESBL (extended-spectrum β-lactamase, for some class A)Cephalosporinase (for class C)
02

Mechanism of action

Hydrolysis (inactivation) of the β-lactam ring in antibiotics, leading to antibiotic resistance. Drugs (β-lactamase inhibitors) target and inhibit these enzymes to restore antibiotic efficacy

03

Biological functions

Antibiotic resistanceHydrolysis of β-lactam antibiotics
04

Disease associations

Infection (mainly antibiotic-resistant bacterial infections)
05

Safety considerations

Therapeutic challenges due to rapid resistance developmentPotential for cross-resistance or resistance transfer among bacteriaFalse susceptibility in clinical testing (especially if not all β-lactamases are detected)
06

Interacting drugs

β-lactam antibiotics (penicillins, cephalosporins, monobactams, carbapenems)

1 more in the full profile.

07

Biomarkers

Presence of β-lactamase genes (e.g., bla_TEM, bla_SHV, bla_CTX-M for class A; bla_AmpC for class C) in bacterial isolatesNitrocefin test (phenotypic detection of β-lactamase activity)

Beyond the preview

Go deeper on Beta-lactamase class A and beta-lactamase class C enzyme (Class A β-lactamase, Class C β-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase class A and beta-lactamase class C enzyme (Class A β-lactamase, Class C β-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call